Close
Smartlab Europe
Inizio Ignite

Press Releases

Envigo announces collaboration with Biocytogen to distribute the B-NDG triple immunodeficient and humanizable mouse mode

Envigo RMS Holding Corp. announces a collaboration with Biocytogen, a global biotech company that drives the research and development of new drugs with innovative technologies. The two companies are committed to supporting research applications of the triple immunodeficient B-NDG...

FedEx Delivers COVID-19 Vaccines, Test Kits to Vietnam Using Healthcare Expertise

FedEx Express, a subsidiary of FedEx Corp. and one of the world’s largest express transportation companies, has delivered a shipment of COVID-19 vaccines and test kits on September 23 from Hungary to Vietnam on behalf of PATH, a global...

Vetter’s Contribution to Climate Protection: Corporate Sites Around the World are CO2-Neutral

The “Green Deal” initiated by the European Commission aims at reducing the net emissions of greenhouse gases to zero across the EU by 2050, thereby making the European continent climate-neutral. As a globally operating Contract Development and Manufacturing Organization...

Interphex 2021: Syntegon to showcase new laboratory and small batch solutions for solid and liquid pharmaceuticals

Syntegon (formerly Bosch Packaging Technology) presents new solutions for lab-scale and small batch filling of solid and liquid pharmaceuticals. “The need for smaller quantities of highly potent drugs is rising continuously. We have put these solutions in the focus...

BD Completes Study Investigating Performance of Glass Prefillable Syringes in Deep Cold Storage

BD (Becton, Dickinson and Company), a leading global medical technology company, completed a preliminary study investigating the impact of deep cold storage (-20°C and -40°C) on glass PFS. While traditional vaccine formulations are commonly stored up to about 2°C-8°C, new...

Celltrion’s regdanvimab becomes the first authorized COVID-19 treatment approved from the Korean MFDS

Celltrion Group announced that the Korean Ministry of Food and Drug Safety (MFDS) approved regdanvimab (CT-P59), a monoclonal antibody treatment for COVID-19 for the extended use in elderly patients aged 50 years and over, or with at least one...

RedHill Biopharma Reports Top-Line Data from Opaganib Phase 2/3 Study in Severe COVID-19 Patients

RedHill Biopharma Ltd. , a specialty biopharmaceutical company, announced preliminary top-line data from the 475-patient global Phase 2/3 study with opaganib (ABC294640) in hospitalized patients with severe COVID-19 pneumonia. Preliminary top-line data showed that the study did not meet its...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »